Atherogenic dyslipidemia: Lipoprotein abnormalities and implications for therapy
- 1 February 1995
- journal article
- review article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 75 (6) , 45B-52B
- https://doi.org/10.1016/0002-9149(95)80011-g
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Lipoproteins and AtherogenesisJAMA, 1990
- Lipoprotein-Mediated Cellular Mechanisms for Atherogenesis in HypertriglyceridemiaSeminars in Thrombosis and Hemostasis, 1988
- Total cholesterol and high density lipoprotein cholesterol levels in populations differing in fat and carbohydrate intake.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1987
- Association between dietary fat intake and plasma factor VII coagulant activity — A predictor of cardiovascular mortalityAtherosclerosis, 1986
- Apolipoprotein E is the determinant that mediates the receptor uptake of beta-very low density lipoproteins by mouse macrophages.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1986
- Assay of factor VII activity by two techniques: evidence for increased conversion of VII to αVIIain hyperlipidaemia, with possible implications for ischaemic heart diseaseBritish Journal of Haematology, 1985
- Familial Dysbetalipoproteinemia: New Aspects of Pathogenesis and DiagnosisMedical Clinics of North America, 1982
- Transfer of plasma lipoprotein components and of plasma proteins into aortas of cholesterol-fed rabbits. Molecular size as a determinant of plasma lipoprotein influx.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1981
- The plasma lipids, lipoproteins, and diet of the Tarahumara Indians of MexicoThe American Journal of Clinical Nutrition, 1978
- Plasma Lipids and Lipoproteins in Vegetarians and ControlsNew England Journal of Medicine, 1975